ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,910Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 223

$706K Total Retail Price of All Prescriptions

Rank: 25 out of 223

643 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 643 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 643 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 8,582 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
SIMVASTATIN 475 433 1 1
LEVOTHYROXINE SODIUM 329 303 2 2
OMEPRAZOLE 316 289 3 3
AMLODIPINE BESYLATE 238 229 4 6
ZOLPIDEM TARTRATE 202 174 5 8
MELOXICAM 189 166 6 33
HYDROCODONE-ACETAMINOPHEN 184 125 S3 7 5
TRAMADOL HCL 182 135 8 18
SERTRALINE HCL 158 139 9 21
LOSARTAN-HYDROCHLOROTHIAZIDE 153 149 10 31
CARVEDILOL 152 142 11 23
FLUTICASONE PROPIONATE 144 128 12 27
ATORVASTATIN CALCIUM 142 131 13 17
BISOPROLOL-HYDROCHLOROTHIAZIDE 136 120 14 129
METFORMIN HCL 134 113 15 7
GABAPENTIN 124 104 16 10
CITALOPRAM HBR 123 115 17 16
NABUMETONE 121 115 18 127
LOSARTAN POTASSIUM 120 104 19 14
WARFARIN SODIUM 115 104 20 11
ALENDRONATE SODIUM 114 110 21 19
LEVOXYL 114 105 21 78
LISINOPRIL 112 106 23 4
FUROSEMIDE 111 102 24 9
CRESTOR 102 101 25 37
POTASSIUM CHLORIDE 100 80 26 12
SYNTHROID 100 89 26 35
GLIMEPIRIDE 97 94 28 30
METFORMIN HCL ER 91 71 29 41
CYMBALTA 90 83 30 40
HYDROCHLOROTHIAZIDE 90 90 30 13
DONEPEZIL HCL 89 89 32 36
PRAVASTATIN SODIUM 84 78 33 15
TAMSULOSIN HCL 82 61 34 26
NAMENDA 81 81 35 48
BENAZEPRIL HCL 77 74 36 57
FLUOXETINE HCL 76 63 37 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 72 38 29
INSULIN SYRINGE 70 47 39 81
METOPROLOL SUCCINATE 69 66 40 20
PANTOPRAZOLE SODIUM 69 65 40 45
PREMARIN 68 61 R 42 115
SPIRONOLACTONE 66 62 43 55
VERAPAMIL ER 65 62 44 89
BENAZEPRIL-HYDROCHLOROTHIAZIDE 63 61 45 135
CELEBREX 62 52 46 42
OXYBUTYNIN CHLORIDE ER 61 61 47 109
TRAZODONE HCL 61 52 47 22
SPIRIVA 54 46 49 82
DICLOFENAC SODIUM 53 53 50 76
LANTUS 52 45 51 34
AMITRIPTYLINE HCL 52 48 R 51 61
AMLODIPINE BESYLATE-BENAZEPRIL 50 50 53 105
ESTRADIOL 50 44 R 53 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.